This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

A Promising New Clinical Investigative Procedure

Daniel Finkelstein, MD; John G. Clarkson, MD

Arch Ophthalmol. 1995;113(4):421-422.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

WE ARE INDEBTED to McAllister and Constable¹ for introducing new hope for the management of retinal vein occlusion, as reported in this issue of the ARCHIVES. As a very common retinal vascular disorder, probably second only to diabetic retinopathy, and as a disorder that frequently does not seem to respond to therapy, the vision loss of vein occlusion frustrates both the patient and the ophthalmologist. All patients with vein occlusion must live in fear of the 10% chance that vein occlusion will occur in the fellow eye as well.

Therapies at present are limited. For branch vein occlusion, the Collaborative Branch Vein Occlusion Study showed that laser grid photocoagulation brought some small benefit by improving visual acuity that was reduced because of perfused macular edema.² For neovascularization secondary to ischemic branch vein occlusion, scatter photocoagulation in the affected quadrant reduces but does not eliminate vitreous hemorrhage.³ For . . . [Full Text PDF of this Article]

Author Affiliations
Baltimore, Md; Miami, Fla

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?